Onconetix (ONCO) Competitors $4.83 +0.60 (+14.18%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$4.76 -0.07 (-1.37%) As of 07/14/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONCO vs. TLPH, CLDI, LSB, AEON, ARTL, DWTX, JBIO, KPRX, CLRB, and CHROShould you be buying Onconetix stock or one of its competitors? The main competitors of Onconetix include Talphera (TLPH), Calidi Biotherapeutics (CLDI), LakeShore Biopharma (LSB), AEON Biopharma (AEON), Artelo Biosciences (ARTL), Dogwood Therapeutics (DWTX), Jade Biosciences (JBIO), Kiora Pharmaceuticals (KPRX), Cellectar Biosciences (CLRB), and Chromocell Therapeutics (CHRO). These companies are all part of the "pharmaceutical products" industry. Onconetix vs. Its Competitors Talphera Calidi Biotherapeutics LakeShore Biopharma AEON Biopharma Artelo Biosciences Dogwood Therapeutics Jade Biosciences Kiora Pharmaceuticals Cellectar Biosciences Chromocell Therapeutics Talphera (NASDAQ:TLPH) and Onconetix (NASDAQ:ONCO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation. Is TLPH or ONCO more profitable? Talphera has a net margin of 0.00% compared to Onconetix's net margin of -2,913.71%. Talphera's return on equity of -130.28% beat Onconetix's return on equity.Company Net Margins Return on Equity Return on Assets TalpheraN/A -130.28% -59.25% Onconetix -2,913.71%-514.04%-75.82% Does the media favor TLPH or ONCO? In the previous week, Talphera and Talphera both had 1 articles in the media. Talphera's average media sentiment score of 1.89 equaled Onconetix'saverage media sentiment score. Company Overall Sentiment Talphera Very Positive Onconetix Very Positive Do institutionals & insiders believe in TLPH or ONCO? 37.7% of Talphera shares are owned by institutional investors. Comparatively, 23.9% of Onconetix shares are owned by institutional investors. 3.2% of Talphera shares are owned by insiders. Comparatively, 3.1% of Onconetix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer TLPH or ONCO? Talphera currently has a consensus price target of $5.00, indicating a potential upside of 955.07%. Given Talphera's stronger consensus rating and higher possible upside, research analysts clearly believe Talphera is more favorable than Onconetix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Onconetix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, TLPH or ONCO? Talphera has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Onconetix has a beta of 3.38, meaning that its share price is 238% more volatile than the S&P 500. Which has better earnings & valuation, TLPH or ONCO? Talphera has higher earnings, but lower revenue than Onconetix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalphera$27K359.87-$13M-$0.45-1.05Onconetix$2.52M1.02-$58.69MN/AN/A SummaryTalphera beats Onconetix on 11 of the 13 factors compared between the two stocks. Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCO vs. The Competition Export to ExcelMetricOnconetixMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.56M$2.95B$5.54B$9.14BDividend YieldN/A2.43%5.01%4.00%P/E RatioN/A21.1628.6819.45Price / Sales1.02184.72374.0179.78Price / CashN/A41.0524.7227.47Price / Book0.437.758.255.58Net Income-$58.69M-$55.05M$3.19B$252.81M7 Day Performance0.63%9.69%3.60%2.11%1 Month Performance2.11%13.80%9.60%11.87%1 Year Performance-99.03%3.55%30.55%16.61% Onconetix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOOnconetix0.5693 of 5 stars$4.83+14.2%N/A-99.1%$2.56M$2.52M0.0012Positive NewsTLPHTalphera2.0081 of 5 stars$0.47+1.9%$5.00+959.3%-49.0%$9.66M$27K-1.0519CLDICalidi Biotherapeutics0.5678 of 5 stars$0.30+24.1%N/A-63.4%$9.47MN/A0.0038Gap DownHigh Trading VolumeLSBLakeShore Biopharma0.7476 of 5 stars$1.20+21.9%N/A-76.4%$9.26M$80.82M0.00773Gap DownHigh Trading VolumeAEONAEON Biopharma2.4229 of 5 stars$0.81+2.6%$360.00+44,235.0%-99.2%$9.18MN/A4.515ARTLArtelo Biosciences2.6304 of 5 stars$16.59+15.9%$25.00+50.7%+138.8%$9.13MN/A-0.935Gap DownHigh Trading VolumeDWTXDogwood Therapeutics1.8943 of 5 stars$4.71+2.3%$10.00+112.5%N/A$8.99MN/A-0.265JBIOJade Biosciences2.3075 of 5 stars$10.42-0.3%$14.00+34.4%N/A$8.76MN/A-0.1720Analyst ForecastKPRXKiora Pharmaceuticals3.2118 of 5 stars$2.87+2.0%$10.00+249.0%-27.2%$8.72MN/A-0.9910CLRBCellectar Biosciences2.5635 of 5 stars$4.82+0.3%$375.00+7,688.2%-93.4%$8.72MN/A-0.2210Positive NewsCHROChromocell TherapeuticsN/A$1.34+6.3%N/A-88.3%$8.69MN/A-1.084Gap UpHigh Trading Volume Related Companies and Tools Related Companies TLPH Alternatives CLDI Alternatives LSB Alternatives AEON Alternatives ARTL Alternatives DWTX Alternatives JBIO Alternatives KPRX Alternatives CLRB Alternatives CHRO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCO) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.